CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

Abstract

The purpose of this study was to investigate the effect of adding sustained-release (SR) bupropion to cognitive behavioral therapy (CBT) on smoking behavior and stability of psychiatric symptoms in patients with schizophrenia. We conducted a 3-month, double-blind, placebo-controlled trial of bupropion SR, 150 mg/day, added to a concurrent CBT program with 3-month follow-up in 19 stable outpatients with schizophrenia who wanted to quit smoking. Eighteen subjects completed the trial. Bupropion treatment was associated with significantly greater reduction in smoking, as measured by self-report verified by expired-air carbon monoxide (6/9 subjects, 66%), than placebo (1/9 subjects, 11%) during the 3-month active treatment period and the 3-month follow-up period. One subject in the bupropion group (11%) and no subjects in the placebo group achieved sustained tobacco abstinence for the 6-month trial. Bupropion treatment was associated with improvement in negative symptoms and greater stability of psychotic and depressive symptoms, compared with placebo, during the quit attempt. Subjects in the bupropion group experienced significant weight loss, compared with those on placebo during the smoking cessation attempt. These data suggest that bupropion SR, 150 mg/day, combined with CBT, may facilitate smoking reduction in patients with schizophrenia while stabilizing psychiatric symptoms during a quit attempt.

Overview

Integrity signals

Registry

Crossref · 10.1080/14622200110073920

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 191

Metadata

Authors
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C.
Affiliations
Harvard University (US)
Corresponding author
Evins, A. Eden
Venue
Nicotine & Tobacco Research
Published
2001-11-01
Volume
3
Issue
4
Pages
397-403
ISSN
  • 1462-2203 (ISSN-L)
  • 1469-994X
OpenAlex
W2062555412
Cited by
191
References
30
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 12 · 2014: 6 · 2013: 2 · 2012: 16
FWCI
6.97
Type
journal article
Language
en
Open access
closed
Locations
  • Nicotine & Tobacco Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r03da012542-02)
  • National Institute on Drug Abuse (R03 DA12542-01)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
bupropion, cognitive behavioral therapy, smoking cessation, schizophrenia, nicotine dependence, bupropion sustained release, negative symptoms, psychotic symptoms, depressive symptoms, weight loss, smoking abstinence
MeSH terms
Aged, Combined Modality Therapy, Delayed-Action Preparations, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Pilot Projects, Schizophrenia, Time Factors, Tobacco Use Disorder, Cognitive Behavioral Therapy, Smoking Cessation, Bupropion, Dopamine Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. https://app.cochat.ai/papers/10.1080/14622200110073920
The paper
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research. https://doi.org/10.1080/14622200110073920

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.